Biological Safety Testing Market
Biological Safety Testing Market Size, Share & Trends Analysis Report by Product & Services (Kits & Reagents, Instruments, and Testing Services) by Test Type (Sterility Testing, Endotoxin Testing, Bioburden Testing, Cell Line Authentication & Characterization, Adventitious Agent Detection, Residual Host Contaminant Detection, and Others) and by End User (Pharmaceutical & Biotechnology Companies, CROs / CDMOs, Academic & Research Institutes, and Medical Device Companies) Forecast Period, (2026-2035)
Industry Overview
Biological safety testing market valued at $6,203.5 million in 2025 and is projected to reach $16,411.1 million by 2035, growing at a CAGR of 10.3% during the forecast period (2026-2035). The global biological safety testing market is progressing steadily as biopharmaceutical companies, contract research organizations, and vaccine manufacturers intensify their focus on ensuring product safety, regulatory compliance, and quality assurance throughout the development lifecycle. Growth is being supported by the increasing complexity of biologics, including monoclonal antibodies, cell and gene therapies, and vaccines, which require rigorous contamination and safety validation. Rising adoption of advanced detection technologies such as rapid microbiological methods, PCR-based assays, and automated endotoxin testing systems is further strengthening testing efficiency. Demand is also being driven by stringent regulatory frameworks mandating comprehensive safety testing for biologics before commercialization. As the industry prioritizes risk mitigation and product integrity, biological safety testing solutions are becoming essential for maintaining compliance and accelerating approval timelines.
Market Dynamics
Rising Demand for Biologics and Advanced Therapeutics Driving Testing Requirements
The rapid expansion of biologics, biosimilars, and advanced therapy medicinal products is significantly increasing the need for robust biological safety testing solutions. Pharmaceutical and biotechnology companies are focusing on ensuring that products are free from contaminants such as bacteria, viruses, mycoplasma, and endotoxins. This has led to the growing adoption of specialized testing services and kits across multiple stages of drug development and manufacturing. As biologics production scales globally, manufacturers are prioritizing high-quality, validated safety testing systems to maintain regulatory compliance and product consistency. This surge in biologics development continues to act as a primary growth driver for the market.
Technological Advancements in Rapid and Automated Testing Solutions
Innovations in rapid microbiological methods, automation, and molecular diagnostics are transforming biological safety testing workflows. Advanced platforms leveraging PCR, next-generation sequencing, and automated detection systems are enabling faster and more accurate identification of contaminants. These technologies reduce turnaround times compared to traditional culture-based methods, helping companies accelerate batch release and improve operational efficiency. Vendors are increasingly developing integrated systems that support high-throughput testing and digital data management. As the need for speed and precision in testing grows, the adoption of technologically advanced solutions is emerging as a key factor shaping market expansion.
Market Segmentation
- Based on the product & services, the market is segmented into kits & reagents, instruments, and testing services.
- based on the test type, the market is segmented into sterility testing, endotoxin testing, bioburden testing, cell line authentication & characterization, adventitious agent detection, residual host contaminant detection, and others.
- based on the end user, the market is segmented into pharmaceutical & biotechnology companies, CROs / CDMOs, academic & research institutes, and medical device companies.
Kits & Reagents Segment to Dominate the Market with the Largest Share
In the global biological safety testing market, the kits & reagents segment is expected to account for the largest market share, driven by their widespread use in routine quality control and safety assessment processes. These products are essential for conducting a wide range of tests, including sterility, endotoxin, and bioburden analysis, ensuring the safety and compliance of biologics, vaccines, and medical devices. The increasing production of biologics and biosimilars, along with stringent regulatory requirements for product safety, is significantly boosting demand for reliable and ready-to-use testing kits. Additionally, advancements in assay sensitivity, rapid testing technologies, and automation compatibility are improving efficiency and turnaround times. These factors collectively reinforce the dominance of the kits & reagents segment in the market.
Sterility Testing: A Key Segment in Market Growth
The sterility testing segment plays a critical role in driving growth within the biological safety testing market, owing to its fundamental importance in ensuring that pharmaceutical and biopharmaceutical products are free from viable contaminants. Regulatory authorities mandate sterility testing as a crucial step in the manufacturing and release of injectable drugs, vaccines, and cell-based therapies. The rising demand for sterile biologics, increasing adoption of advanced aseptic manufacturing processes, and growing emphasis on patient safety are significantly contributing to segment expansion. Furthermore, technological advancements such as rapid microbiological methods and automated detection systems are enhancing accuracy, reducing testing time, and improving compliance. Together, these factors position sterility testing as a major contributor to overall market growth.
Regional Outlook
The global biological safety testing market is further divided by geography, including North America (the US and Canada), Europe (the UK, Germany, France, Italy, Spain, Russia, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, Australia and New Zealand, ASEAN Countries, and the Rest of Asia-Pacific), and the Rest of the World (the Middle East & Africa, and Latin America).
Expansion of Biopharmaceutical Manufacturing in Asia-Pacific
The Asia-Pacific region is witnessing significant growth in the biological safety testing market due to the rapid expansion of biopharmaceutical manufacturing capabilities. Countries across the region are investing in biotechnology infrastructure, contract manufacturing, and research facilities, driving the demand for safety testing solutions. Increasing participation in global clinical trials and the production of vaccines and biosimilars are further contributing to the need for stringent testing protocols. Additionally, regulatory authorities in the region are strengthening compliance standards, encouraging the adoption of advanced testing technologies. This evolving ecosystem is positioning Asia-Pacific as a key growth hub for biological safety testing.
North America Region Dominates the Market with Major Share
North America holds a dominant position in the biological safety testing market, supported by its well-established biopharmaceutical industry and strong regulatory framework. The region benefits from the presence of leading pharmaceutical companies, advanced research institutions, and a high level of investment in biologics and vaccine development. Regulatory agencies emphasize stringent safety and quality standards, driving consistent demand for comprehensive testing solutions. Furthermore, the widespread adoption of advanced analytical technologies and automation is enhancing testing efficiency across laboratories. These factors collectively reinforce North America’s leadership in the global market.
Market Players Outlook
The major companies operating in the global biological safety testing market includes Charles River Laboratories International, Inc., Eurofins Scientific SE, Lonza Group AG, Merck KGaA, Thermo Fisher Scientific Inc., among others. Market players are leveraging partnerships, collaborations, mergers and acquisition strategies for business expansion and innovative product development to maintain their market positioning.
Recent Developments
- In May 2025, Thermo Fisher Scientific introduced an advanced rapid sterility testing platform designed to significantly reduce testing time while maintaining high accuracy, supporting faster biologics release and improved manufacturing efficiency.
- In March 2025, Charles River Laboratories expanded its biologics safety testing portfolio with enhanced viral clearance and mycoplasma detection services, strengthening its capabilities to support complex biologic drug development.
The Report Covers
- Market value data analysis of 2025 and forecast to 2035.
- Annualized market revenues ($ million) for each market segment.
- Country-wise analysis of major geographical regions.
- Key companies operating in the global biological safety testing Based on the availability of data, information related to new products and relevant news is also available in the report.
- Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
- Analysis of market-entry and market expansion strategies.
- Competitive strategies by identifying ‘who-stands-where’ in the market.
- Report Summary
- Current Industry Analysis and Growth Potential Outlook
- Global Biological Safety Testing Market Sales Analysis – Product & Services | Test Type | End User ($ Million)
- Biological Safety Testing Market Sales Performance of Top Countries
- Research Methodology
- Primary Research Approach
- Secondary Research Approach
- Market Snapshot
- Market Overview and Insights
- Scope of the Study
- Analyst Insight & Current Market Trends
- Key Biological Safety Testing Market Trends
- Market Recommendations
- Porter's Five Forces Analysis for the Biological Safety Testing Market
- Competitive Rivalry
- Threat of New Entrants
- Bargaining Power of Suppliers
- Bargaining Power of Buyers
- Threat of Substitutes
- Market Determinants
- Market Drivers
- Drivers For Global Biological Safety Testing Market: Impact Analysis
- Market Pain Points and Challenges
- Restraints For Global Biological Safety Testing Market: Impact Analysis
- Market Opportunities
- Opportunities For Global Biological Safety Testing Market: Impact Analysis
- Market Drivers
- Competitive Landscape
- Competitive Dashboard – Biological Safety Testing Market Revenue and Share by Manufacturers
- Biological Safety Testing Product Comparison Analysis
- Top Market Player Ranking Matrix
- Key Company Analysis
- Charles River Laboratories International, Inc.
- Overview
- Product Portfolio
- Financial Analysis
- SWOT Analysis
- Business Strategy
- Eurofins Scientific SE
- Overview
- Product Portfolio
- Financial Analysis
- SWOT Analysis
- Business Strategy
- Lonza Group AG
- Overview
- Product Portfolio
- Financial Analysis
- SWOT Analysis
- Business Strategy
- Merck KGaA
- Overview
- Product Portfolio
- Financial Analysis
- SWOT Analysis
- Business Strategy
- Thermo Fisher Scientific Inc.
- Overview
- Product Portfolio
- Financial Analysis
- SWOT Analysis
- Business Strategy
- Top Winning Strategies by Market Players
- Merger and Acquisition
- Product Launch
- Partnership and Collaboration
- Charles River Laboratories International, Inc.
- Key Company Analysis
- Global Biological Safety Testing Market Sales Analysis by Product & Services ($ Million)
- Kits & Reagents
- Instruments
- Testing Services
- Global Biological Safety Testing Market Sales Analysis by Test Type ($ Million)
- Sterility Testing
- Endotoxin Testing
- Bioburden Testing
- Cell Line Authentication & Characterization
- Adventitious Agent Detection
- Residual Host Contaminant Detection
- Others
- Global Biological Safety Testing Market Sales Analysis by End User ($ Million)
- Pharmaceutical & Biotechnology Companies
- CROs / CDMOs
- Academic & Research Institutes
- Medical Device Companies
- Regional Analysis
- North American Biological Safety Testing Market Sales Analysis – Product & Services | Test Type | End User | Country ($ Million)
- Macroeconomic Factors for North America
- United States
- Canada
- European Biological Safety Testing Market Sales Analysis – Product & Services | Test Type | End User | Country ($ Million)
- Macroeconomic Factors for Europe
- UK
- Germany
- Italy
- Spain
- France
- Russia
- Rest of Europe
- Asia-Pacific Biological Safety Testing Market Sales Analysis – Product & Services | Test Type | End User | Country ($ Million)
- Macroeconomic Factors for Asia-Pacific
- China
- Japan
- South Korea
- India
- Australia & New Zealand
- ASEAN Countries (Thailand, Indonesia, Vietnam, Singapore, And Other)
- Rest of Asia-Pacific
- Rest of the World Biological Safety Testing Market Sales Analysis – Product & Services | Test Type | End User | Country ($ Million)
- Macroeconomic Factors for Rest of the World
- Latin America
- Middle East and Africa
- Company Profiles
- Agilent Technologies, Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- bioMérieux SA
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Bio-Rad Laboratories, Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Charles River Laboratories International, Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Danaher Corporation
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Eurofins Scientific SE
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Hoffmann-La Roche Ltd
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- FUJIFILM Holdings Corporation
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Lonza Group AG
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Merck KGaA
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Pall Corporation
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- PerkinElmer, Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Promega Corporation
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- QIAGEN N.V.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Sartorius AG
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- SGS SA
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Thermo Fisher Scientific Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- TÜV SÜD AG
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- WuXi AppTec Co., Ltd.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- WuXi Biologics (Cayman) Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Agilent Technologies, Inc.
1. Global Biological Safety Testing Market Research and Analysis by Product & Services, 2025–2035 ($ Million)
2. Global Kits & Reagents Biological Safety Testing Market Research and Analysis by Region, 2025–2035 ($ Million)
3. Global Instruments Biological Safety Testing Market Research and Analysis by Region, 2025–2035 ($ Million)
4. Global Testing Services Biological Safety Testing Market Research and Analysis by Region, 2025–2035 ($ Million)
5. Global Biological Safety Testing Market Research and Analysis by Test Type, 2025–2035 ($ Million)
6. Global Sterility Testing Biological Safety Testing Market Research and Analysis by Region, 2025–2035 ($ Million)
7. Global Endotoxin Testing Biological Safety Testing Market Research and Analysis by Region, 2025–2035 ($ Million)
8. Global Bioburden Testing Biological Safety Testing Market Research and Analysis by Region, 2025–2035 ($ Million)
9. Global Cell Line Authentication & Characterization Testing Biological Safety Testing Market Research and Analysis by Region, 2025–2035 ($ Million)
10. Global Adventitious Agent Detection Biological Safety Testing Market Research and Analysis by Region, 2025–2035 ($ Million)
11. Global Residual Host Contaminant Detection Biological Safety Testing Market Research and Analysis by Region, 2025–2035 ($ Million)
12. Global Others Biological Safety Testing Market Research and Analysis by Region, 2025–2035 ($ Million)
13. Global Biological Safety Testing Market Research and Analysis by End User, 2025–2035 ($ Million)
14. Global Biological Safety Testing for Pharmaceutical & Biotechnology Companies Market Research and Analysis by Region, 2025–2035 ($ Million)
15. Global Biological Safety Testing for CROs / CDMOs Market Research and Analysis by Region, 2025–2035 ($ Million)
16. Global Biological Safety Testing for Academic & Research Institutes Market Research and Analysis by Region, 2025–2035 ($ Million)
17. Global Biological Safety Testing for Medical Device Companies Market Research and Analysis by Region, 2025–2035 ($ Million)
18. Global Biological Safety Testing Market Research and Analysis by Region, 2025–2035 ($ Million)
19. North American Biological Safety Testing Market Research and Analysis by Country, 2025–2035 ($ Million)
20. North American Biological Safety Testing Market Research and Analysis by Product & Services, 2025–2035 ($ Million)
21. North American Biological Safety Testing Market Research and Analysis by Test Type, 2025–2035 ($ Million)
22. North American Biological Safety Testing Market Research and Analysis by End User, 2025–2035 ($ Million)
23. European Biological Safety Testing Market Research and Analysis by Country, 2025–2035 ($ Million)
24. European Biological Safety Testing Market Research and Analysis by Product & Services, 2025–2035 ($ Million)
25. European Biological Safety Testing Market Research and Analysis by Test Type, 2025–2035 ($ Million)
26. European Biological Safety Testing Market Research and Analysis by End User, 2025–2035 ($ Million)
27. Asia-Pacific Biological Safety Testing Market Research and Analysis by Country, 2025–2035 ($ Million)
28. Asia-Pacific Biological Safety Testing Market Research and Analysis by Product & Services, 2025–2035 ($ Million)
29. Asia-Pacific Biological Safety Testing Market Research and Analysis by Test Type, 2025–2035 ($ Million)
30. Asia-Pacific Biological Safety Testing Market Research and Analysis by End User, 2025–2035 ($ Million)
31. Rest of the World Biological Safety Testing Market Research and Analysis by Region, 2025–2035 ($ Million)
32. Rest of the World Biological Safety Testing Market Research and Analysis by Product & Services, 2025–2035 ($ Million)
33. Rest of the World Biological Safety Testing Market Research and Analysis by Test Type, 2025–2035 ($ Million)
34. Rest of the World Biological Safety Testing Market Research and Analysis by End User, 2025–2035 ($ Million)
1. Global Biological Safety Testing Market Share by Device Type, 2025 Vs 2035 (%)
2. Global Kits & Reagents Biological Safety Testing Market Share by Region, 2025 Vs 2035 (%)
3. Global Instruments Biological Safety Testing Market Share by Region, 2025 Vs 2035 (%)
4. Global Testing Services Biological Safety Testing Market Share by Region, 2025 Vs 2035 (%)
5. Global Biological Safety Testing Market Research and Analysis by Test Type, 2025 Vs 2035 (%)
6. Global Sterility Testing Biological Safety Testing Market Share by Region, 2025 Vs 2035 (%)
7. Global Endotoxin Testing Biological Safety Testing Market Share by Region, 2025 Vs 2035 (%)
8. Global Bioburden Testing Biological Safety Testing Market Share by Region, 2025 Vs 2035 (%)
9. Global Cell Line Authentication & Characterization Testing Biological Safety Testing Market Share by Region, 2025 Vs 2035 (%)
10. Global Adventitious Agent Detection Biological Safety Testing Market Share by Region, 2025 Vs 2035 (%)
11. Global Residual Host Contaminant Detection Biological Safety Testing Market Share by Region, 2025 Vs 2035 (%)
12. Global Others Biological Safety Testing Market Share by Region, 2025 Vs 2035 (%)
13. Global Biological Safety Testing Market Research and Analysis by End User, 2025 Vs 2035 (%)
14. Global Biological Safety Testing for Pharmaceutical & Biotechnology Companies Market Share by Region, 2025 Vs 2035 (%)
15. Global Biological Safety Testing for CROs / CDMOs Market Share by Region, 2025 Vs 2035 (%)
16. Global Biological Safety Testing for Academic & Research Institutes Market Share by Region, 2025 Vs 2035 (%)
17. Global Biological Safety Testing for Medical Device Companies Market Share by Region, 2025 Vs 2035 (%)
18. Global Biological Safety Testing Market Research and Analysis by Region, 2025–2035 ($ Million)
19. US Biological Safety Testing Market Size, 2025–2035 ($ Million)
20. Canada Biological Safety Testing Market Size, 2025–2035 ($ Million)
21. UK Biological Safety Testing Market Size, 2025–2035 ($ Million)
22. France Biological Safety Testing Market Size, 2025–2035 ($ Million)
23. Germany Biological Safety Testing Market Size, 2025–2035 ($ Million)
24. Italy Biological Safety Testing Market Size, 2025–2035 ($ Million)
25. Spain Biological Safety Testing Market Size, 2025–2035 ($ Million)
26. Russia Biological Safety Testing Market Size, 2025–2035 ($ Million)
27. Rest of Europe Biological Safety Testing Market Size, 2025–2035 ($ Million)
28. India Biological Safety Testing Market Size, 2025–2035 ($ Million)
29. China Biological Safety Testing Market Size, 2025–2035 ($ Million)
30. Japan Biological Safety Testing Market Size, 2025–2035 ($ Million)
31. South Korea Biological Safety Testing Market Size, 2025–2035 ($ Million)
32. Australia and New Zealand Biological Safety Testing Market Size, 2025–2035 ($ Million)
33. ASEAN Economies Biological Safety Testing Market Size, 2025–2035 ($ Million)
34. Rest of Asia-Pacific Biological Safety Testing Market Size, 2025–2035 ($ Million)
35. Latin America Biological Safety Testing Market Size, 2025–2035 ($ Million)
36. Middle East and Africa Biological Safety Testing Market Size, 2025–2035 ($ Million)
- Printable version
- No restriction to number of users within the company
